Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holger Lerche

Showing results (41-50 of 282) with videos related to

Pageof 29
Sort By:
Clinical Pharmacokinetics|April 11, 2015
Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the LiteratureStefan Wolking, Elke Schaeffeler, Holger Lerche, et al.
Neuroscience Letters|March 4, 2006
Immunohistochemical analysis of KCNQ3 potassium channels in mouse brainJulia Geiger, Yvonne G Weber, Bernhard Landwehrmeyer, et al.
Plos Computational Biology|March 6, 2023
Predicting functional effects of ion channel variants using new phenotypic machine learning methodsChristian Malte Boßelmann, Ulrike B S Hedrich, Holger Lerche, et al.
Frontiers in Immunology|March 26, 2026
Antineuronal antibody titres in autoimmune encephalitis: clinical implications for diagnosis and long-term immunotherapyHanna Schwab, Josua Kegele, Markus C Kowarik, et al.
Molecular Pharmacology|January 22, 2005
The new anticonvulsant retigabine favors voltage-dependent opening of the Kv7.2 (KCNQ2) channel by binding to its activation gateThomas V Wuttke, Guiscard Seebohm, Sigrid Bail, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 6, 2012
Paroxysmal exercise-induced dyskinesia of the handsCamilla N Clark, Yvonne W Weber, Holger Lerche, et al.
Journal of Neurology|May 11, 2016
Letter to the editor: confirming neonatal seizure and late onset ataxia in SCN2A Ala263ValKatrine M Johannesen, Maria J Miranda, Holger Lerche, et al.
Current Pharmaceutical Design|August 17, 2005
Ion channel defects in idiopathic epilepsiesHolger Lerche, Yvonne G Weber, Karin Jurkat-Rott, et al.
Journal of Neurology|April 3, 2019
Strength and muscle structure preserved during long-term therapy in a patient with hypokalemic periodic paralysis (Cav1.1-R1239G)Marc-André Weber, Karin Jurkat-Rott, Holger Lerche, et al.
Seizure|July 29, 2015
Efficacy and safety of ezogabine/retigabine as adjunctive therapy to specified single antiepileptic medications in an open-label study of adults with partial-onset seizuresHolger Lerche, Jerzy Daniluk, Narinder Lotay, et al.
Pageof 29

Showing results (41-50 of 282) with videos related to

Sort By:
Pageof 29
Clinical Pharmacokinetics|April 11, 2015
Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the LiteratureStefan Wolking, Elke Schaeffeler, Holger Lerche, et al.
Neuroscience Letters|March 4, 2006
Immunohistochemical analysis of KCNQ3 potassium channels in mouse brainJulia Geiger, Yvonne G Weber, Bernhard Landwehrmeyer, et al.
Plos Computational Biology|March 6, 2023
Predicting functional effects of ion channel variants using new phenotypic machine learning methodsChristian Malte Boßelmann, Ulrike B S Hedrich, Holger Lerche, et al.
Frontiers in Immunology|March 26, 2026
Antineuronal antibody titres in autoimmune encephalitis: clinical implications for diagnosis and long-term immunotherapyHanna Schwab, Josua Kegele, Markus C Kowarik, et al.
Molecular Pharmacology|January 22, 2005
The new anticonvulsant retigabine favors voltage-dependent opening of the Kv7.2 (KCNQ2) channel by binding to its activation gateThomas V Wuttke, Guiscard Seebohm, Sigrid Bail, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 6, 2012
Paroxysmal exercise-induced dyskinesia of the handsCamilla N Clark, Yvonne W Weber, Holger Lerche, et al.
Journal of Neurology|May 11, 2016
Letter to the editor: confirming neonatal seizure and late onset ataxia in SCN2A Ala263ValKatrine M Johannesen, Maria J Miranda, Holger Lerche, et al.
Current Pharmaceutical Design|August 17, 2005
Ion channel defects in idiopathic epilepsiesHolger Lerche, Yvonne G Weber, Karin Jurkat-Rott, et al.
Journal of Neurology|April 3, 2019
Strength and muscle structure preserved during long-term therapy in a patient with hypokalemic periodic paralysis (Cav1.1-R1239G)Marc-André Weber, Karin Jurkat-Rott, Holger Lerche, et al.
Seizure|July 29, 2015
Efficacy and safety of ezogabine/retigabine as adjunctive therapy to specified single antiepileptic medications in an open-label study of adults with partial-onset seizuresHolger Lerche, Jerzy Daniluk, Narinder Lotay, et al.
Pageof 29